Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial
Academic Article
Publication Date:
2021
Short description:
Rapamycin Plus Vildagliptin to Recover ß Cell Function in Long Standing Type 1 Diabetes: A Double Blind Randomized Trial / Bolla, A.M., Gandolfi, A., Borgonovo, E., Laurenzi, A., Caretto, A., Molinari, C., Catalano, R.S., Bianconi, E., Monti, P., Sordi, V., Pellegrini, S., Lampasona, V., Costa, S., Scavini, M., Bosi, E., Piemonti, L.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 106:2(2021), pp. 507-519. [10.1210/clinem/dgaa791]
abstract:
The aim of this study was to investigate whether treatment with rapamycin plus vildagliptin restores beta-cell function in patients with long-standing type 1 diabetes.
Iris type:
1.1 Articolo in rivista
List of contributors:
Bolla, Andrea Mario; Gandolfi, Alessandra; Borgonovo, Elisa; Laurenzi, Andrea; Caretto, Amelia; Molinari, Chiara; Catalano, Roberta Sara; Bianconi, Eleonora; Monti, Paolo; Sordi, Valeria; Pellegrini, Silvia; Lampasona, Vito; Costa, Sabrina; Scavini, Marina; Bosi, Emanuele; Piemonti, Lorenzo
Published in: